Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.
about
miRNAs As Emerging Regulators of Oligodendrocyte Development and DifferentiationIs It worth Considering Circulating microRNAs in Multiple Sclerosis?Biomarkers of therapeutic response in multiple sclerosis: current statusFunction and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver DiseaseMir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.Expression, regulation and function of microRNAs in multiple sclerosisCirculating miR-150 in CSF is a novel candidate biomarker for multiple sclerosisNatalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the futureMicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progressionQuantification of plasma microRNAs in a group of healthy smokers, ex-smokers and non-smokers and correlation to biomarkers of tobacco exposure.miR-23a, miR-146a and miR-301a confer predisposition to Vogt-Koyanagi-Harada syndrome but not to Behcet's disease.Dicer and microRNA expression in multiple sclerosis and response to interferon therapy.Meta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis.Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis PatientsThe emerging role of circulating microRNAs as biomarkers in autoimmune diseases.Body fluid biomarkers for multiple sclerosis--the long road to clinical application.Epigenetic Modifications and Therapy in Multiple Sclerosis.Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.miRNAs as biomarkers of neurodegenerative disorders.Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.MicroRNA-149* suppresses hepatic inflammatory response through antagonizing STAT3 signaling pathway.Regulation of miRNA processing and miRNA mediated gene repression in cancerExosomal microRNA signatures in multiple sclerosis reflect disease status.miRCarta: a central repository for collecting miRNA candidates.miRNA-23a/CXCR4 regulates neuropathic pain via directly targeting TXNIP/NLRP3 inflammasome axis.Circulating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis.[MiRNAs: new actors in the physiopathology of multiple sclerosis].Circulating microRNAs as biomarkers in progressive multiple sclerosis.Dysregulated MicroRNA Involvement in Multiple Sclerosis by Induction of T Helper 17 Cell Differentiation.Differentially expressed microRNA in multiple sclerosis: A window into pathogenesis?Neuronal microRNA regulation in Experimental Autoimmune Encephalomyelitis
P2860
Q26744461-F7DAC6C3-3998-48CE-B056-2670A33D9C6FQ26752505-1815F112-8127-4B43-BB41-9A019FB68A68Q27012726-495E7AC8-4518-4F2C-854D-1ED61E0055D7Q28073703-4E59EBF1-8CA2-45A7-A5A1-0C874A9765B3Q33653403-CFE8E49F-33FE-4995-A0B7-2C8378817880Q33754662-7114BF13-A6DF-43D9-9338-4C86814150CAQ34524908-0E067D94-DF35-4B2A-B9C9-302CDE35FFB8Q34994463-B9412159-9E18-4008-9FBA-4C43D292EE34Q35078327-D90D4737-D7D3-4E1B-8372-57778B7FA43CQ35599410-8D572EB1-A5BB-41D8-8C7B-70FAFB0105A0Q36357339-0C5CFD5A-84A4-4AD0-A232-A25675E0755CQ36512305-F81C571D-D73E-42E7-9337-A04BC539F2FBQ36655150-28AF7ADE-C612-475E-8796-36CDE68CDDEBQ37050779-43F0B44D-CC8E-47BB-8B83-FE3B9EEEAF1CQ37232023-2655876F-DAC6-43C2-B555-374602AF136FQ38222306-F308F600-3930-47BB-9EA8-C3670D4E07FFQ38590773-B7A521EB-F9C7-45E2-9717-E4523175A0F3Q38887611-646BECCF-4ABE-4B95-B275-AAE7D247C995Q38984981-E12D7894-0CF9-499F-9170-14E1C5ECE542Q39104808-8DFA8763-75F2-4AEE-ACC8-0B2E78407317Q41942567-C45CBF4B-F165-4990-80D8-0075AC785EB2Q42371538-C25D4096-2CCC-42BF-A9A8-6D24276B9AB9Q42540826-398C9515-135F-4BCE-9C0A-DF7621E99502Q45812827-4EC3AE41-7E2C-4063-9685-E985E3863A2CQ47152432-C1724541-045A-4F00-B73D-EEB06D9D3A54Q47828526-5332E5DF-3578-4515-AF44-029E7910E4D4Q49165904-DE91D233-989F-49E8-88B0-00796587DE6EQ49485817-DA4CB4FF-C459-4D85-8629-BAC23FE2AFFCQ53751609-6E384EE6-0DA9-4534-821E-93458ADFB133Q55265126-CA4DF73D-62D0-45EA-AFA8-45D2274774B9Q56688688-DB780C88-0BBB-4299-BA6C-090FB3E9E5C7Q57039772-D7B4658F-4B01-4624-A160-C1093A7659F1
P2860
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Decreased circulating miRNA le ...... rogressive multiple sclerosis.
@en
Decreased circulating miRNA le ...... rogressive multiple sclerosis.
@nl
type
label
Decreased circulating miRNA le ...... rogressive multiple sclerosis.
@en
Decreased circulating miRNA le ...... rogressive multiple sclerosis.
@nl
prefLabel
Decreased circulating miRNA le ...... rogressive multiple sclerosis.
@en
Decreased circulating miRNA le ...... rogressive multiple sclerosis.
@nl
P2093
P2860
P50
P356
P1476
Decreased circulating miRNA le ...... rogressive multiple sclerosis.
@en
P2093
Becky J Parks
Claudia Cantoni
Elisa Ridolfi
Laura M Piccio
Maria Serpente
Milena De Riz
Robert T Naismith
Rossana Bonsi
P2860
P304
P356
10.1177/1352458513485654
P50
P577
2013-12-01T00:00:00Z